HemoCue A Quest Diagnostics Company
HemoCue® AB develops, produces, and markets medical diagnostic products for point-of-care testing. The fundamental concept behind the HemoCue® products is the ability to perform common blood and urine tests at the point-of-care.
In addition to providing accurate point-of-care testing products, HemoCue® is dedicated to delivering safe and regulatory compliant products of high quality to the user.
Read company related articles in this section.
New Website
HemoCue® is proud to introduce our new website! It has been enhanced with new information, is searchable and will take you into the new HemoCue®…
 | Read more |  |
HemoCue® victorious in patent validity fight vs. EKF Diagnostics
PRESS RELEASE 2010-11 HemoCue® microcuvette patent prevails in German court battle against EKF Diagnostics...
| Read more | |
HemoCue® AB Establishes South Africa Subsidiary
PRESS RELEASE 2009-11 HemoCue® AB has established a subsidiary, HemoCue® South Africa (Pty) Limited...
| Read more | |
Hospital Laboratory Connectivity
PRESS RELEASE 2009-06 HemoCue® Inc., the U.S. point-of-care testing distribution subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), announced that it has signed an agreement with Medical Automation Systems, Inc. (MAS)...
| Read more | |
First FDA CLIA Waiver for quantitative POC Albumin test
PRESS RELEASE 2008-06 HemoCue® Albumin 201 system is the first quantitative point-of-care test, for screening for, diagnosing and monitoring microalbuminuria...
| Read more | |
Page 1 of 4
| Previous |  | | Next | |
More Information
We are happy to provide additional information – please contact us:
Information missing?
